GG 261
Pill imprint GG 261 has been identified as Meclizine hydrochloride 25 mg.
Meclizine is used in the treatment of vertigo; motion sickness; nausea/vomiting and belongs to the drug class anticholinergic antiemetics. There is no proven risk in humans during pregnancy.
Meclizine 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Meclizine hydrochloride Images
- Imprint:
-
GG 261
- Strength:
- 25 mg
- Color:
- Yellow
- Shape:
- Elliptical / Oval
- Availability:
- Rx and/or OTC
- Drug Class:
- Anticholinergic antiemetics
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00781-1375
| NDC Code | Manufacturer / Repackager |
|---|---|
| 63739-0163 | McKesson Packaging Services |
| 55289-0159 | PDRX Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Meclizine Hydrochloride resources
- Meclizine
- Meclizine (Wolters Kluwer)
- Meclizine Chewable Tablets (Wolters Kluwer)
- meclizine (Cerner Multum)
- Meclizine Hydrochloride (AHFS DI)
- Meclizine (FDA)
- Meclizine (Wolters Kluwer)
Search Again
